Skip Navigation



Human Molecular Genetics Advance Access published online on December 16, 2008
Human Molecular Genetics, doi:10.1093/hmg/ddn420
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
18/5/911    most recent
ddn420v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Pagenstecher, A.
Right arrow Articles by Felbor, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pagenstecher, A.
Right arrow Articles by Felbor, U.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells

Axel Pagenstecher1,#, Sonja Stahl2,#, Ulrich Sure3 and Ute Felbor2,*

1 Department of Neuropathology, University of Marburg, Germany 2 Department of Human Genetics, University of Würzburg, Germany 3 Department of Neurosurgery, University of Essen, Germany

* Communicating author: Prof. Dr. U. Felbor, MD Department of Human Genetics, University of Würzburg, Biocentre, Am Hubland D-97074 Würzburg, Germany felbor{at}biozentrum.uni-wuerzburg.de Tel.: (+)49-931-888 4096, Fax: (+)49-931-888 4069

Cavernous vascular malformations occur with a frequency of 1:200 and can cause recurrent headaches, seizures, and hemorrhagic stroke if located in the brain. Familial cerebral cavernous malformations (CCM) have been associated with germline mutations in CCM1/KRIT1, CCM2 or CCM3/PDCD10. For each of the three CCM genes, we here show complete localized loss of either CCM1, CCM2 or CCM3 protein expression depending on the inherited mutation. Cavernous but not adjacent normal or reactive endothelial cells of known germline mutation carriers displayed immunohistochemical negativity only for the corresponding CCM protein but not for the two others. In addition to proving loss of function at the protein level, our data are the first to demonstrate endothelial cell mosaicism within cavernous tissues and provide clear pathogenetic evidence that the endothelial cell is the cell of disease origin.

# Axel Pagenstecher and Sonja Stahl have contributed equally.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 StrokeHome page
G. G. Leblanc, E. Golanov, I. A. Awad, W. L. Young, and Biology of Vascular Malformations of the Brain NIN
Biology of Vascular Malformations of the Brain
Stroke, December 1, 2009; 40(12): e694 - e702.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.